NSE · MARKSANS
Marksans Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#438
of 5,084 stocks
🏆 New peak
▲ 371W
Peak #438 · 30 Sep 2026
Marksans Pharma Limited, a midcap Healthcare business, is growing revenue rapidly, commands a premium earnings multiple, and earns a healthy return on equity.
Market Cap
15,532.06 Cr
P/E Ratio
37.17
P/B Ratio
5.09
ROE
13.76%
ROCE
17.54%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 840.80 Cr | 856.11 Cr | 754.43 Cr | 720.41 Cr |
| Net Profit | 159.41 Cr | 149.03 Cr | 113.69 Cr | 99.14 Cr |
| EPS | 3.47 | 3.27 | 2.50 | 2.17 |
| Operating Profit | 213.58 Cr | 206.31 Cr | 156.56 Cr | 139.15 Cr |
Shareholding pattern
Promoter
43.87%
Public
56.13%
PUBLIC BREAKDOWN
FII
17.47%
DII
6.19%
MF (within DII)
4.36%
Individuals
29.58%
Mutual fund holdings
₹427.29
Cr total
15
Schemes
6
Fund Houses
₹427.29 Cr
Total Exposure
UTI Mutual Fund₹267.36 Cr (62.6%)
Kotak Mahindra Mutual Fund₹140.23 Cr (32.8%)
Motilal Oswal Mutual Fund₹18.20 Cr (4.3%)
Samco Mutual Fund₹1.36 Cr (0.3%)
Groww Mutual Fund₹0.12 Cr (0.0%)
Others₹0.02 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 20 Aug 2026 | Dividend | Dividend - Re 0.90 Per Share |
| 01 Aug 2025 | Dividend | Dividend - Re 0.80 Per Share |
| 17 Sep 2024 | Dividend | Dividend - Rs 0.60 Per Share |
| 07 Jun 2023 | Dividend | Dividend - Re 0.50 Per Share |
| 19 Aug 2022 | Dividend | Annual General Meeting/Dividend - Rs 0.25 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.